David Grinblatt to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications David Grinblatt has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.047
-
A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma. Cancer. 1998 Oct 15; 83(8):1540-5.
Score: 0.037
-
Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancer. Cytotherapy. 2000; 2(3):179-85.
Score: 0.010